PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Top Cited Papers
- 6 October 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 2 (52), 52ra73
- https://doi.org/10.1126/scitranslmed.3001059
Abstract
Parkinson’s disease affects 5 million people worldwide, but the molecular mechanisms underlying its pathogenesis are still unclear. Here, we report a genome-wide meta-analysis of gene sets (groups of genes that encode the same biological pathway or process) in 410 samples from patients with symptomatic Parkinson’s and subclinical disease and healthy controls. We analyzed 6.8 million raw data points from nine genome-wide expression studies, and 185 laser-captured human dopaminergic neuron and substantia nigra transcriptomes, followed by two-stage replication on three platforms. We found 10 gene sets with previously unknown associations with Parkinson’s disease. These gene sets pinpoint defects in mitochondrial electron transport, glucose utilization, and glucose sensing and reveal that they occur early in disease pathogenesis. Genes controlling cellular bioenergetics that are expressed in response to peroxisome proliferator–activated receptor γ coactivator-1α (PGC-1α) are underexpressed in Parkinson’s disease patients. Activation of PGC-1α results in increased expression of nuclear-encoded subunits of the mitochondrial respiratory chain and blocks the dopaminergic neuron loss induced by mutant α-synuclein or the pesticide rotenone in cellular disease models. Our systems biology analysis of Parkinson’s disease identifies PGC-1α as a potential therapeutic target for early intervention.Keywords
This publication has 69 references indexed in Scilit:
- Chipping away at diagnostics for neurodegenerative diseasesNeurobiology of Disease, 2009
- α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityNature Genetics, 2009
- A critical evaluation of the Braak staging scheme for Parkinson's diseaseAnnals of Neurology, 2008
- Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insultsFree Radical Biology & Medicine, 2008
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2008
- Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseActa Neuropathologica, 2007
- Effects of gender on nigral gene expression and parkinson diseaseNeurobiology of Disease, 2007
- An integrative genomics approach to infer causal associations between gene expression and diseaseNature Genetics, 2005
- Loss of Apolipoprotein E Receptor LR11 in Alzheimer DiseaseArchives of Neurology, 2004
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003